Bruno Pougault/LinkedIn
Oct 5, 2026, 12:51
Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
Bruno Pougault, Global Marketing Hemostasis Product Manager at HORIBA ABX SAS, shared a post on LinkedIn:
“New episode out now on Hemostasis Pulse! Is your Anti-Xa assay giving you the true physiological picture of your patient?
In this new episode, we explore the critical importance of Anti-Xa reagent selection and pre-analytical rigor for heparin monitoring (UFH amp; LMWH), fully grounded in guidelines from learned societies (ISTH, BSH, SFH, SFTH, and ASH).
What you will learn in this episode:
- Why traditional aPTT falls short due to acute-phase reactants and lupus anticoagulant interferences.
- The Dextran Sulfate Trap: How certain Anti-Xa reagents artificially overestimate residual heparin after protamine reversal in cardiac and vascular surgery.
- Pre-analytical vigilance: The crucial 60-minute centrifugation window to prevent Platelet Factor 4 (PF4) release and heparin neutralization.
- Analytical excellence: The power of two-step chromogenic assays with exogenous antithrombin. Featuring expert insights from Bruno Pougault (Global International Hemostasis Product Manager).
Listen now on Spotify.
Also streaming on Apple Podcasts on our channel Hemostasis Pulse!
How is your institution handling Anti-Xa reagent selection and pre-analytical sample turnaround?”
Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series